TITLE

Combination therapy for hypertension

PUB. DATE
February 2009
SOURCE
Travel Medicine Advisor;Feb2009 Supplement, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the different drug combinations to antidotes converting enzyme (ACE) inhibitor for treatment of hypertension in patients at risk for cardiovascular disease. Based on research conducted in several medical schools in the U.S. and Sweden, the combination of ACE inhibitor- benazepril and calcium channel blocker amlodipine is superior to the combination of benazepril and diuretic- hydrochlorothiazide in reducing risk of cardiovascular attacks to patients hypertension.
ACCESSION #
36364693

 

Related Articles

  • The ASCOT Trial: Clarifying the Role of ACE Inhibition in the Reduction of Cardiovascular Events in Patients with Hypertension. Meurin, Philippe // American Journal of Cardiovascular Drugs;2006, Vol. 6 Issue 5, p327 

    Hypertension remains one of the primary causes of preventable death in developed countries. Universally accepted clinical practice guidelines based on well designed trials are needed to ensure standardized treatment for these patients. It has been hypothesized that agents such as calcium...

  • Combination Therapy for Hypertension. Crawford, Michael // Clinical Cardiology Alert;Jan2009, Vol. 28 Issue 1, p3 

    The article reports on the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial. The study involves the angiotensin converting enzyme inhibitor (ACE I) benazepril plus diuretic against benazepril plus the calcium blocker...

  • Antihypertensive agents and renal protection: Calcium channel blockers. SARUTA, TAKAO; KANNO, YOSHIHIKO; HAYASHI, KOICHI; KONISHI, KONOSUKE // Kidney International Supplement;Jun1996, Issue 55, pS-52 

    This study defines the nature of the renal protective effects of calcium channel blockers (Ca blockers) and the effects of the Ca blocker, amlodipine, compared to those of the angiotensin-converting enzyme inhibitor (ACEI), enalapril, on the progression of renal injury in 5/6 nephrectomized...

  • Two-drug hypertension regimen increases CVD mortality.  // BMJ: British Medical Journal (International Edition);3/19/2005, Vol. 330 Issue 7492, p608 

    Asks if any other drug, in addition to diuretics, can effectively reduce adverse cardiovascular events in the treatment of adults with hypertension. Superiority of diuretics to other agents as a first line therapy for most patients with hypertension; Study of women taking calcium channel...

  • Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension. Hilleman, D E; Reyes, A P; Wurdeman, R L; Faulkner, M // Journal of Human Hypertension;Aug2001, Vol. 15 Issue 8, p559 

    Background: Recent hypertension trials have demonstrated the importance of achieving goal blood pressures to reduce the risk of target organ damage. In patients with moderate to severe hypertension, the use of high-dose monotherapy and/or combinations of drugs are necessary to achieve these...

  • How Best to Control Hypertension? Elliott, William T. // Primary Care Reports;Feb2009 Pharmacology Watch, p1 

    The article discusses ways to control hypertension, with a focus on various drug combinations. It is claimed that one of the best combination for the treatment of hypertension patients at risk for cardiovascular disease is an ACE inhibitor/diuretic combination product. However, some studies...

  • Revealed: trusts block GPs' choice over BP drugs. Wilkinson, Emma; Neville, Sarah // Pulse;8/10/2006, Vol. 66 Issue 31, p2 

    The article reports that doctors are being prohibited to prescribe a choice of first-line treatments for hypertension by financially troubled primary care organizations. It is a direct challenge to new NICE guidelines in Great Britain. Doctors will be restricted to prescribe diuretics even...

  • GPs angered by drug restrictions.  // Pulse;8/10/2006, Vol. 66 Issue 31, p2 

    The article reports on the reaction of general practitioners in Great Britain to the moves to attempt to restrict hypertension drugs choice. The NICE guidelines are misleading according to doctors. Calcium channel blockers are effective and cost-effective too. It is a disservice to patient to...

  • Secondary stroke prophylaxis: ARB bests calcium antagonist.  // Formulary;May2005, Vol. 40 Issue 5, p157 

    Discusses a study which suggested that the angiotensin receptor blocker (ARB) eprosartan is superior to the calcium antagonist nitrendipine in secondary stroke prophylaxis in patients with hypertension. Findings reported by Dr. Hans-Chrisdan Diener at the American Stroke Association's...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics